戻る Agenda
Session 3 / Venue 5: Virtual Meeting of PMDA’s Scientific Consultation: Points to Maximize an Efficiency of the Meeting ~ (Japanese Language Only)
Session Chair(s)
Yoshiaki Uyama, PhD, RPh
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
It is critical for both applicant and regulator to have proper understanding of the objectives of the consultation including the background or fundamental problems faced in order to implement the meeting result. In reality, however, the usefulness or comprehension varies depending on how the issues are addressed or how the opinions are written in the briefing or response materials. The panelists replicate common consultation by using virtual new product, which will provide some ideas on how to avoid miscommunication and how to maximize the value of consultation.
Speaker(s)
[V5-S3] Virtual Meeting of PMDA’s Scientific Consultation: Points to Maximize an Efficiency of the Meeting ~ (Japanese Language Only)
Yoshiaki Uyama, PhD, RPh
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director